Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

4.100 -0.100 (-2.38%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	159,564
Open	4.170
Bid (Size)	4.100 (1,200)
Ask (Size)	4.130 (100)
Prev. Close	4.200
Today's Range	4.070 - 4.225
52wk Range	2.070 - 4.980
Shares Outstanding	32,916,915
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗

September 09, 2025

3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.

Via MarketBeat

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent ↗

April 09, 2025

Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future immunotherapy options.

Via Benzinga

Performance

YTD	+73.0%	+73.0%
1 Month	-4.4%	-4.4%
3 Month	+37.6%	+37.6%
6 Month	+51.9%	+51.9%
1 Year	+34.4%	+34.4%

More News

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 08, 2025

Via Benzinga

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines ↗

March 25, 2025

Via Benzinga

Recap: Anixa Biosciences Q1 Earnings ↗

March 12, 2024

Via Benzinga

EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine ↗

March 24, 2025

Via Benzinga

This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗

March 21, 2025

Via Benzinga

iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024

December 06, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 30, 2024

Via Benzinga

Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying ↗

July 29, 2024

Via Benzinga

EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy ↗

July 23, 2024

Via Benzinga

EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program ↗

July 15, 2024

Via Benzinga

ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 ↗

June 04, 2024

Via InvestorPlace

7 Penny Biotech Stocks to Triple Your Investment ↗

May 28, 2024

Via InvestorPlace

Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference

May 16, 2024

Via Investor Brand Network

Sidoti Events, LLC's Virtual May Micro-Cap Conference

May 07, 2024

Via ACCESSWIRE

Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth

March 20, 2024

Via AB Newswire

Sidoti Events, LLC's Virtual January Micro-Cap Conference

January 15, 2024

Via ACCESSWIRE

Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape? ↗

December 20, 2023

Via Benzinga

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 ↗

December 11, 2023

Via InvestorPlace

Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says 'Exceeded Expectations' ↗

December 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 07, 2023

Via Benzinga

The 3 Most Undervalued Cheap Stocks to Buy in September 2023 ↗

September 11, 2023

Via InvestorPlace

Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?

August 10, 2023

Via ACCESSWIRE

Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer? ↗

August 09, 2023

Via Benzinga

Frequently Asked Questions

Is Anixa Biosciences, Inc. - Common Stock publicly traded?

Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Anixa Biosciences, Inc. - Common Stock trade on?

Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?

The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market

What is the current price of Anixa Biosciences, Inc. - Common Stock?

The current price of Anixa Biosciences, Inc. - Common Stock is 4.100

When was Anixa Biosciences, Inc. - Common Stock last traded?

The last trade of Anixa Biosciences, Inc. - Common Stock was at 11/18/25 04:00 PM ET

What is the market capitalization of Anixa Biosciences, Inc. - Common Stock?

The market capitalization of Anixa Biosciences, Inc. - Common Stock is 134.96M

How many shares of Anixa Biosciences, Inc. - Common Stock are outstanding?

Anixa Biosciences, Inc. - Common Stock has 135M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.